Literature DB >> 16785470

Gefitinib for epidermal growth factor receptor mutant lung cancers: searching for a weapon of mass destruction.

Pasi A Jänne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785470     DOI: 10.1200/JCO.2006.06.6555

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers.

Authors:  Daniel B Costa; Susumu Kobayashi; Daniel G Tenen; Mark S Huberman
Journal:  Lung Cancer       Date:  2007-07-03       Impact factor: 5.705

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.